(Q48668016)

English

The phosphodiesterases type 5 inhibitor tadalafil reduces the activation of the hypothalamus-pituitary-adrenal axis in men during cycle ergometric exercise.

scientific article published on 7 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

The phosphodiesterases type 5 inhibitor tadalafil reduces the activation of the hypothalamus-pituitary-adrenal axis in men during cycle ergometric exercise. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

Maria Chiara Gallotta

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

Gian Pietro Emerenziani

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

9

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

10

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

author name string

Luigi Di Luigi

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

Paolo Sgrò

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

Clara Crescioli

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

Serena Bianchini

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

Francesco Romanelli

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

publication date

7 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

302

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

E972-8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Psychophysical bases of perceived exertion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Relationships among training stress, mood and dehydroepiandrosterone sulphate/cortisol ratio in female cyclists.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Stress and disorders of the stress system

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Supplements and the endocrine system in athletes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

The Long-Acting Phosphodiesterase Inhibitor Tadalafil does not Influence Athletes' V·O2max, Aerobic, and Anaerobic Thresholds in Normoxia

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

The type 5 phosphodiesterase inhibitor tadalafil influences salivary cortisol, testosterone, and dehydroepiandrosterone sulphate responses to maximal exercise in healthy men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Do non-steroidal anti-inflammatory drugs influence the steroid hormone milieu in male athletes?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Central nitric oxide regulation of the hypothalamic-pituitary-adrenocortical axis in adult male rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Effect of tadalafil on anaerobic performance indices in healthy athletes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Androgen misuse and abuse

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Sensitivity to stress-induced reproductive dysfunction is associated with a selective but not a generalized increase in activity of the adrenal axis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Exercise and circulating cortisol levels: the intensity threshold effect

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Growth hormone, IGF-I and insulin and their abuse in sport.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Chronic inhibition of nitric oxide synthase augments the ACTH response to exercise

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Phosphodiesterase regulation of nitric oxide signaling

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Cardiovascular effects of tadalafil

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Hormonal responses and adaptations to resistance exercise and training

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Dissociation of ACTH, beta-endorphin and cortisol in graded sepsis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Corticotroph axis sensitivity after exercise: comparison between elite athletes and sedentary subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Relationships among plasma dehydroepiandrosterone sulfate and cortisol levels, symptoms of dissociation, and objective performance in humans exposed to acute stress

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Effects of high-intensity isokinetic exercise on salivary cortisol in athletes with different training schedules: relationships to serum cortisol and lactate

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam Experience Study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Sympathetic activation by sildenafil.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Dysregulation of corticosterone secretion in streptozotocin-diabetic rats: modulatory role of the adrenocortical nitrergic system

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Transient global amnesia after intake of tadalafil, a PDE-5 inhibitor: a possible association?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Modulatory effect of L-NAME, a specific nitric oxide synthase (NOS) inhibitor, on stress-induced changes in plasma adrenocorticotropic hormone (ACTH) and corticosterone levels in rats: physiological significance of stress-induced NOS activation in h

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Cortisol--essential adaptation hormone in exercise

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Exposure to nitrous oxide stimulates a nitric oxide-dependent neuronal release of beta-endorphin in ventricular-cisternally-perfused rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00573.2011

21 January 2018

Identifiers

10.1152/AJPENDO.00573.2011

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22318947

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48668016&oldid=1319351110"